The shares of Helmerich & Payne, Inc. (NYSE:HP) started off the last trading session with the price of $64.5 while closing the day with the price of $66.79. The shares of Helmerich & Payne, Inc. (NYSE:HP) Rise 2.47% with the Gain of 2.29 points.
The shares of Helmerich & Payne, Inc. (NYSE:HP) traded with the day volume of 1.21 Million shares whereas its average trading volume is 1.78 Million.
While analyzing the past performance of the stock we can see that the shares of Helmerich & Payne, Inc. (NYSE:HP) Loss -0.1% in the last week while Falling -7.27% in the last month. Past quarter performance shows the green light with 17.09%. The semi-annual and annual performance shows 56.6% and -2.45% respectively.
Some critical values of the shares of Helmerich & Payne, Inc. (NYSE:HP) to be discussed here are: the beta which shows the value at 1.37 while Average True Range of Helmerich & Payne, Inc. (NYSE:HP) demonstrate the value at 2.34. The weekly and monthly volatility of the shares of Helmerich & Payne, Inc. (NYSE:HP) are indicated at 3.39% and 3.58%. Also to discuss here is the Relative Strength Index or RSI which is depicted at 51.01.
While studying the financial position of the shares of Helmerich & Payne, Inc. (NYSE:HP), we can see that the Market capitalization of the company is at 7.1 Billion. The shares outstanding for the company is 106.24 Million and the shares float stands at 105.66 Million. The income of the company stand at 902.8 Million while the sales stand at 2 Billion.
Here are some critical ratios for a financial perspective: Earnings Per Share or EPS of the company stand at 8.27, Price to Earnings or P/E is at 8.08, Price to Sales P/S show the value of 3.55, the Return on Asset ROA stood at 0.062 and the Return on Equity ROE depicted at 0.093 while Return on Investment ROI is at -0.025.
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) started its previous trading session at $4.87 and closed at $5.03 showing a Rise of 2.44 Percent.
The Company traded with an average Volume of 1.3 Million whereas, its Day Volume stood at 1.21 Million.
Looking at the performance of the stock, BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Gain 0.2% in the last week in its shares price and 11.78% in the last month. Quarterly performance shows a green of 7.48 Percent while Semi-Annual and Annual performances shows a 1.21 and -32.21 percent respectively.
Beta for BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) stands at 2.73 while the ATR (average true range) is at 0.28. The Stock’s Weekly and Monthly Volatility is 5.21% and 5.88% respectively showing a RSI value of 52.19.
While studying the financial position of the shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX), we can see that the Market capitalization of the company is at 483.18 Million. The shares outstanding for the company is 96.06 Million and the shares float stands at 96.06 Million.
The Company generated an income of -65800000 and the sales of 25.2 Million in the Trailing Twelve Months period.
While analyzing the stock from technical aspects, Diluted Earnings per share stands at $-0.78 a share. P/E (price to earnings) and P/S (price to sales) values are 0 and 19.17 respectively.
The Return on Assets stands at -0.36, ROE shows a value of -1.144 and ROI for BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) is -0.879 as of Trailing Twelve Months period.
